¼¼°èÀÇ Ç³¼±ÆÇ¸·¼ºÇü¼ú µð¹ÙÀ̽º ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ¿¬·ÉÃþº°, ÃÖÁ¾ ¿ëµµº° - ¿¹Ãø(2024-2032³â)
Balloon Valvuloplasty Devices Market - By Product Type (Standard, Cutting, Scoring Balloon), Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), Age Group (Pediatric, Adult), End-use (Hospitals, ASCs) - Global Forecast (2024 - 2032)
»óǰÄÚµå : 1532486
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,716,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,378,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,563,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Ç³¼±ÆÇ¸·¼ºÇü¼ú µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð´Â ÇコÄɾî ÁöÃâ Áõ°¡ ¹× ÇコÄɾî ÀÎÇÁ¶óÀÇ Áøº¸·Î 2024³âºÎÅÍ 2032³â±îÁö CAGR 4.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ì±¹ ÀÇ»çȸ¿¡ µû¸£¸é ¹Ì±¹ÀÇ °Ç°­ °ü¸® ÁöÃâÀº 2022³â 4.1% Áõ°¡ÇÑ 4Á¶ 5,000¾ï ´Þ·¯, ±¹¹Î 1Àδç 1¸¸ 3,493´Þ·¯¿¡ À̸£·¶½À´Ï´Ù. ÀÌ Áõ°¡´Â ½ÉÀå Ä¡·á¸¦ °³¼±Çϱâ À§ÇØ °í±Þ Ä¡·á¿¡ ´ëÇÑ ÅõÀÚ È®´ë¸¦ Áö¿øÇÕ´Ï´Ù.

ÃÖ±Ù¿¡´Â °Ç°­ °ü¸® ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó dz¼±ÆÇ¸·¼ºÇü¼úÀ» Æ÷ÇÔÇÑ Çõ½ÅÀûÀÎ Ä¡·á¿¡ Å« ÀÚ¿øÀÌ ÇÒ´çµÇ¾ú½À´Ï´Ù. ÀÇ·á½Ã¼³ÀÇ È®´ë ¹× Ãæ½Ç¿¡ ÀÇÇØ °íµµÀÇ Ä¡·á¿¡ ´ëÇÑ ¾×¼¼½ºµµ Çâ»óÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ dz¼±ÆÇ¸·¼ºÇü¼úÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖÀ¸¸ç ½ÉÀå ÆÇ¸·Áõ Ä¡·á¿¡¼­ dz¼±ÆÇ¸·¼ºÇü¼úÀÌ ´õ¿í Ä£¼÷Çϰí È¿°úÀûÀÔ´Ï´Ù.

dz¼±ÆÇ¸·¼ºÇü¼ú ½ÃÀåÀº Á¦Ç° À¯Çüº°, ¿ëµµº°, ¿¬·É´ëº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°À¸·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î Á¼Àº ½ÉÀå ÆÇ¸·ÀÇ Ä¡·á ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Ä¿ÆÃ dz¼± ºÎ¹®ÀÌ 2024³â¿¡¼­ 2032³â±îÁö Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. Ä¿ÆÃ dz¼±Àº ÀüÅëÀûÀÎ ¿Ü°ú ¼ö¼ú¿¡ ºñÇØ ³·Àº ħ½ÀÀûÀÎ ¿É¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ½ÉÀå Ä¡·á °³¼±¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³¯Ä«·Î¿î ºí·¹À̵尡 ÀÖ´Â Ä¿ÆÃ dz¼±Àº ¹ëºê Á¶Á÷¿¡ Á¤È®ÇÑ ³ëÄ¡¸¦ ³Ö¾î ¹ëºê¸¦ ³ÐÈ÷°í Á¤»óÀûÀÎ Ç÷·ù¸¦ ȸº¹½ÃŰ´Â ÇùÂøÁõ Ä¡·á¿¡ Å« ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)ÀÇ ÃÖÁ¾ ¿ëµµ ºÎ¹®ÀÇ Ç³¼±ÆÇ¸·¼ºÇü¼ú µð¹ÙÀ̽º »ê¾÷Àº ½ÉÀå Áúȯ ȯÀÚ¿¡°Ô Àü¹®ÀûÀÎ Ä¡·á¸¦ Á¦°øÇÒ Çʿ伺ÀÌ ³ô¾ÆÁö°í 2024³âºÎÅÍ 2032³â±îÁö Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. dz¼±ÆÇ¸·¼ºÇü¼ú µð¹ÙÀ̽º´Â Á¼Àº ½ÉÀå ÆÇ¸· ȯÀÚ¸¦ Ä¡·áÇϱâ À§ÇØ ÀÌ ¼¾ÅÍ¿¡¼­ »ç¿ëµË´Ï´Ù. ÀÌ ±â¼úÀº ȯÀÚÀÇ °á°ú¿Í ȸº¹ ½Ã°£À» °³¼±Çϱâ À§ÇØ Àúħ½À Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)´Â ÀÌ·¯ÇÑ µð¹ÙÀ̽º¸¦ Ä¡·á¿¡ µµÀÔÇÔÀ¸·Î½á ȯÀÚ¿¡°Ô ´õ ¾ÈÀüÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀ» Á¦°øÇÏ°í ½ÉÀå Ä¡·áÀÇ ÃÖÀü¼±¿¡ ¼­´Â °ÍÀ» º¸ÀåÇÕ´Ï´Ù.

Áö¿ªº°·Î´Â À¯·´ÀÇ Ç³¼±ÆÇ¸·¼ºÇü¼ú µð¹ÙÀ̽º »ê¾÷Àº °í·ÉÈ­¿Í ½ÉÀåÇ÷°ü Ä¡·áÀÇ È®´ë¿¡ ÈûÀÔ¾î 2024³âºÎÅÍ 2032³â±îÁö °ßÁ¶ÇÑ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ÀÇ·á Á¦°ø¾÷ü´Â ½ÉÀå ÆÇ¸·ÀÇ »óŸ¦ º¸´Ù È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ÀÌ·¯ÇÑ µð¹ÙÀ̽º¸¦ äÅÃÇÕ´Ï´Ù. À̾î ÀÇ·á±â¼úÀÇ ±Þ¼ÓÇÑ Áøº¸¿Í °í·ÉÈ­ »çȸÀÇ º¹ÀâÇÑ »óȲ¿¡ ´ëÀÀÇϱâ À§ÇØ, º¸´Ù ³ôÀº Á¤¹Ðµµ¿Í Äɾî·Î º¸´Ù ¸¹Àº ¼ö¼úÀÌ ÀÌ·ç¾îÁö°Ô µÇ¾î, À¯·´ Àü¿ª¿¡¼­ÀÇ Á¦Ç° µµÀÔÀÌ ÃËÁøµÉ Àü¸ÁÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°(2021-2032³â)

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°(2021-2032³â)

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿¬·ÉÃþº°(2021-2032³â)

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2032³â)

Á¦9Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°(2021-2032³â)

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Balloon Valvuloplasty Devices Market size is predicted to record 4.8% CAGR from 2024 to 2032, due to the rising healthcare expenditure and advancements in healthcare infrastructure. According to the American Medical Association, the healthcare spending in the U.S. increased by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This rise is supporting greater investment in advanced treatments for improved cardiac care.

Of late, significant resources are being allocated towards innovative treatments, including balloon valvuloplasty on account of the increasing healthcare expenditure. The expansion and enhancement of healthcare facilities are improving access to advanced procedures. In addition, the increasing investments in healthcare infrastructure is supporting the widespread use of balloon valvuloplasty devices, making them more accessible and effective in treating heart valve conditions.

The balloon valvuloplasty devices market is segregated into product type, application, age group, end-use, and region.

By product type, the cutting balloons segment is estimated to grow at a significant rate from 2024 to 2032, due to increasing demand to treat narrowed heart valves. These devices are making significant strides in improving cardiac care by offering a less invasive option compared to traditional surgical methods. Moreover, cutting balloons equipped with sharp blades have a prominent role in treating stenosis by making precise incisions in the valve's tissue which helps in widening the valve and restoring normal blood flow.

Balloon valvuloplasty devices industry from the ambulatory surgical centers end-use segment is expected to rise from 2024 to 2032, fueled by the increasing need for providing specialized care for patients with heart conditions. Balloon valvuloplasty devices are used in these centers to treat patients with narrowed heart valves. This technique allows minimally invasive procedures for improving patient outcomes and recovery times. By integrating these devices into their services, ambulatory surgical centers are ensuring that they are at the forefront of cardiac care for offering patients safer and more effective treatment options.

Regionally, the Europe balloon valvuloplasty devices industry size is anticipated to depict robust growth between 2024 and 2032, propelled by the aging population and the expansion of cardiovascular procedures. Healthcare providers in the region are adopting these devices to manage heart valve conditions more effectively. Subsequently, the rapid advancements in medical technology and the higher volume of procedures to address the complexities of the aging population with enhanced precision and care will drive the product uptake across Europe.

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â